INTRODUCTION
============

*Espinas dendríticas* are small cytoplasmic extensions emerging from the dendrites of neurons that were first described in the cerebellum and cerebrum of birds and mammals by Santiago Ramón y Cajal at the end of the 19th century ([@B86], [@B88], [@B90]; as cited in [@B113]). Cajal had already envisioned that dendritic spines are contacted by axons at synapses ([@B87], [@B89]), and used this arrangement as the main example in support of his *Neuronal Doctrine* ([@B91]). With the aid of electron microscopy and confocal fluorescence microscopy, it is now well established that spines are the postsynaptic sites of most excitatory synapses in the brain, receiving inputs from glutamatergic axons ([@B8]; [@B113]; [@B98]). Despite their small size (∼1 μm in diameter), proper dendritic spine formation is critical for brain function. Numerous proteins, including neurotransmitter and neuropeptide receptors, signaling kinases, and phosphatases, as well as ion channels are expressed in dendritic spines, where they participate in excitatory synaptic transmission and activity-dependent synaptic plasticity, and ultimately in learning and memory ([@B93]). During development and throughout adulthood, the numerical density and morphology of individual spines are critical for the fine-tuning of neuronal and synaptic excitability, allowing the initial establishment and activity-dependent remodeling of connectivity of neuronal circuits ([@B59]).

The morphology of dendritic spines is highly variable, and by defining the biochemical and electrical properties of the postsynaptic compartment, it contributes to the strength and plasticity of excitatory synapses ([@B59]). Spines have been broadly classified into three morphological types: stubby, mushroom and thin ([@B81]). Mushroom spines have a large head that is connected to the parent dendrite through a narrow neck. Stubby spines do not have a noticeable neck and are most common during postnatal development ([@B23]; [@B92]). These two types of large spines are referred to as "memory spines," because they are stable, persist for longer periods of time, and are the postsynaptic side of strong excitatory synapses ([@B104]; [@B52]). Conversely, thin spines have a thin, long neck, and a small bulbous head, are highly motile, unstable, and often short-lived, usually representing weak or silent synapses ([@B92]). Because thin spines are more plastic than large spines and have the potential to become stable spines, they have been dubbed "learning spines" ([@B40]; [@B104]; [@B52]; [@B43]). It should be noted that thin protrusions longer than thin spines and without a noticeable head are called dendritic filopodia, and are more numerous than spines in developing neurons. Dendritic filopodia are transient and highly motile protrusions that can receive synaptic input and develop into mature spines, thus initiating synaptogenesis ([@B35]; [@B59]).

Following the well-known relationship between form and function in biological systems, recent *in vitro* and *in vivo* studies have demonstrated that the morphology of spines relates closely to the function and plasticity of the synapses they belong to ([@B115]; [@B104]; [@B68]; [@B96]; [@B51]). For example, the volume of the spine head is directly proportional to the area of the postsynaptic density and the number of synaptic vesicles docked at the presynaptic active zone ([@B42]; [@B94]), the number of postsynaptic receptors ([@B75]), and hence to the size of synaptic currents and synaptic strength ([@B114]; [@B59]). Two-photon uncaging of glutamate on large spines evoked larger postsynaptic currents mediated by AMPA receptors than uncaging on small spines ([@B65]; [@B51]). Such a structure-function relationship is also evident in the intracellular Ca^2+^ signals within spines triggered by afferent synaptic activity ([@B115]; [@B74]; [@B10]). Together with structural changes in response to afferent synaptic stimulation ([@B70]; [@B101]), all these findings support the long held view that dendritic spines are the morphological substrate of neuronal plasticity and learning and memory ([@B93]). In support of this notion, induction of long-term potentiation (LTP) leads to spine enlargement ([@B66]; [@B78]), whereas long-term depression (LTD) causes spine shrinkage ([@B71]; [@B119]; [@B44]; [@B80]).

The relationship between dendritic spines and cognitive abilities was noted in early studies, when the term "spine dysgenesis" was coined by Dominick Purpura ([@B46]; [@B62]; [@B84]). Such anomalies in the morphology -- and likely function -- of dendritic spines have been described in several neurological disorders associated with cognitive decline, including typical aging, Alzheimer's and Huntington diseases, schizophrenia, neurodevelopmental intellectual disabilities, and autism spectrum disorders ([@B36]; [@B38]; [@B117]; [@B11]; [@B23]; [@B39]; [@B79]; [@B57]).

DENDRITIC SPINE DYSGENESIS IN RETT SYNDROME
===========================================

Rett syndrome (RTT) is an X-linked progressive autism spectrum disorder associated with intellectual disability that affects girls during early childhood (∼1:15,000 birth worldwide; [@B72]; [@B23]). The disorder is characterized by a seemingly typical development for 6 to 18 months followed by regression and onset of a variety of neurological features, including motor impairments, loss of acquired language, intellectual disability, seizures, and anxiety ([@B18]). The majority of RTT individuals carry loss-of-function mutations in *MECP2*, the gene encoding methyl CpG-binding protein 2 (MeCP2), a global transcriptional regulator that binds to methylated CpG sites in promoter regions of DNA ([@B3]; [@B17]). Emerging evidence indicates that RTT results from a deficit in synaptic maturation in the brain, and that MeCP2 plays a critical role in neuronal and synaptic maturation and pruning during development ([@B30]; [@B13]), as well as in the function of established neuronal networks in adulthood ([@B67]).

Pyramidal neurons in the cortex and hippocampus of RTT individuals have dendrites with atypical morphology ([@B6]; [@B4]; [@B22]; **Figure [1A](#F1){ref-type="fig"}**). Two different mouse models lacking *Mecp2* ([@B25]; [@B41]) have reduced dendritic complexity ([@B38]; [@B73]; [@B102]), and decreased dendritic spine density and motility in cortical and hippocampal neurons ([@B7]; [@B105]; [@B55]; [@B21]; [@B16]). On the other hand, *Mecp2^308^* mice expressing truncated MeCP2 ([@B97]), which have impaired synaptic plasticity and hippocampal-dependent learning and memory and other RTT-related neurological deficits, do not show any dendritic or synaptic anomalies neither in cortical nor hippocampal neurons ([@B69]). The reduced dendritic spine density, along with a decrease in the proportion of mushroom spines, is also present in primary hippocampal neurons ([@B20]; [@B5]) and hippocampal slice cultures (**Figure [1B](#F1){ref-type="fig"}**) prepared from newborn *Mecp2* knockout (KO) pups, as well as in neurons derived from induced pluripotent stem cells obtained from RTT individuals ([@B61]).

![**Dendritic spine dysgenesis in Rett syndrome, and intracellular signaling cascades involved in spine plasticity mediated by BDNF and IGF-1. (A)** Confocal images of human CA1 pyramidal neurons in hippocampal sections from autopsy material labeled with DiI. Neurons from RTT individuals have lower dendritic spine density than those from typically developing individuals (Non-ID, non-intellectually disabled). \*\**P* \< 0.01 (adapted from [@B22]).**(B)** Confocal images of apical dendritic segments (top) of eYFP-expressing CA1 pyramidal neurons in 11 days *in vitro* hippocampal slice cultures prepared from postnatal day-5 wildtype (WT) and *Mecp*2 knockout (KO) mice, and their corresponding surface-rendered reconstructions (bottom).**(C)** Schematic diagram of an exemplary excitatory synapse on a dendritic spine of a pyramidal neuron in the hippocampus. We highlight the intracellular signaling cascades that mediate the effects of BDNF and IGF-1 on structural plasticity of spines. TrkB receptors are activated upon binding of BDNF, leading to dimerization and auto-phosphorylation. This process allows for the binding of adaptor proteins to their intracellular domain, and the subsequent activation of Ras/ERK, PI3K, and PLCγ (reviewed by [@B45]). All these pathways have been implicated in the effects of BDNF on dendritic spines (highlighted in red, see text for references). Potential therapies for the treatment of RTT act on these pathways (highlighted in green, see text for details and references): LM22A-4 binds and activates TrkB receptors directly ([@B64]); activation of IGF-1 receptors triggers the PI3K and Ras/ERK signaling pathways ([@B118]). DCV, dense core vesicle; Glu, glutamate; AMPAR, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; NMDAR, *N*-methyl-[D]{.smallcaps}-aspartate receptor; mGluR, metabotropic glutamate receptor; ER, endoplasmic reticulum; RyR, ryanodine receptor; PIP2, phosphatidylinositol 4,5 bisphosphate; DAG, diacylglycerol; IP3, inositol triphosphate; IP3R, IP3 receptor; PKC, protein kinase C; SH-2, src homology domain 2; SHC, SH-2-containing protein; Grb2, growth factor receptor-binding protein 2; GAB1, Grb2-associated-binding protein 1; SOS, nucleotide exchange factor *son-of-sevenless*; Frs2, fibroblast growth factor receptor substrate 2; AKT, protein kinase B; Ras, rat sarcoma proto-oncogenic G-protein; Raf, proto-oncogenic serine/threonine protein kinase; MAPK, mitogen-activated protein kinase; MEK, MAPK kinase; cAMP, cyclic adenosine monophosphate; CREB, cAMP response element-binding protein; IGF-1R, IGF-1 receptor; IRS-1, insulin receptor substrate 1.](fnana-08-00097-g001){#F1}

The spine dysgenesis phenotype in pyramidal neurons of the hippocampus in *Mecp2* KO mice has revealed unexpected complexities. CA1 and CA3 pyramidal neurons have lower spine density only in neonatal (postnatal day-7) *Mecp2* KOs, well before excitatory synapse expansion. Spine density reaches wildtype (WT) levels a week later (postnatal day-15), and is maintained at WT levels throughout the symptomatic stage (postnatal day-40 to 60). Quantitative electron microscopy confirmed that the density of asymmetric spine synapses in CA1 *stratum radiatum* of *Mecp2* KOs is comparable to that of WT mice ([@B12]; [@B21]). This developmental progression of the spine density phenotype is also reflected in the density of excitatory synapses imaged as VGLUT1-PSD95 immunofluorescent puncta, which is lower in area CA1 of 2 week-old *Mecp2* null mice, but comparable to WT levels at 5 weeks of age ([@B20]). Altogether, these data demonstrate that proper MeCP2 functioning is required for dendritic spine formation during early postnatal development, and that a secondary compensatory mechanism seems to take place during atypical development in *Mecp2* KOs. A couple of possibilities exist as to the extent of the compensatory mechanisms necessary to bring spine density to WT levels in hippocampal neurons. One possibility is that enhanced hippocampal network activity in *Mecp2* KOs promotes dendritic spine formation ([@B12]). A second possibility is that deranged homeostatic plasticity promotes spinogenesis, while still affecting pyramidal neuron function ([@B9]; [@B85]).

Consistent with a model that tightly regulated MeCP2 levels are necessary during brain development and adulthood, overexpression of *Mecp2 in vitro* or in the *MECP2* duplication mouse model (*Mecp2*^Tg1^) either increased ([@B49]; [@B20]; [@B48]) or decreased ([@B120]; [@B22]; [@B29]) dendritic complexity, spine density, and the density of excitatory synapses. **Table [1](#T1){ref-type="table"}** sumarizes all the published work on dendritic spines in RTT and experimenal models based on MeCP2 loss-of-function.

###### 

Dendritic spine dysgenesis in RTT individuals and MeCP2-deficient cells and mice.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Source                                                  Brain region                     Preparation                                                            Alterations in dendrites and dendritic spines         Reference
  ------------------------------------------------------- -------------------------------- ---------------------------------------------------------------------- ----------------------------------------------------- --------------
  RTT individuals                                         Cerebral cortex                  Fixed postmortem brain (layer II and III at 2.9--35 years old)         ↓Dendritic complexity\                                [@B6], [@B4]
                                                                                                                                                                  ↓Dendritic spine density                              

                                                          Hippocampus                      Fixed postmortem brain (CA1 region at 1--42 years old)                 ↓Dendritic spine density                              [@B22]

                                                          Induced pluripotent stem cells   Fibroblasts from patients' dermal biopsies (DIV56)                     ↓Excitatory synapse number ↓Dendritic spine density   [@B61]

  *Mecp2*^tm.1.1Bird^                                     Cortex                           Fixed brain (layer II/III motor cortex at P21)                         ↓Dendritic spine density                              [@B7]

                                                                                           Fixed brain (layer II/III somatosensory cortex at P42)                 ↓Dendritic complexity\                                [@B38]
                                                                                                                                                                  ↓Dendritic spine density                              

                                                          Hippocampus                      Autaptic culture (DIV7--9)                                             ↓Excitatory synapse number                            [@B20]

                                                                                           Primary culture (DIV9--15)                                             ↓Excitatory synapse number ↓Dendritic complexity\     [@B5]
                                                                                                                                                                  ↓Dendritic spine density\                             
                                                                                                                                                                  ↓Mushroom spines\                                     
                                                                                                                                                                  ↑Stubby spines                                        

                                                                                           Fixed brain (CA1 region at P21)                                        ↓Dendritic spine density                              [@B7]

                                                                                           Fixed brain (CA1 region at P42)                                        ↓Dendritic complexity\                                [@B73]
                                                                                                                                                                  ↓Dendritic spine density                              

                                                          Fascia dentata                   Fixed brain (P21)                                                      ↓Dendritic spine density                              [@B7]

  *Mecp2*^tm.1.1Jae^                                      Cortex                           *In vivo* and fixed brain (layer V somatosensory cortex at P25, P40)   ↓Dendritic spine density altered spine dynamics       [@B55]

                                                                                           Fixed brain (layer V motor cortex at P40)                              ↓Dendritic complexity\                                [@B102]
                                                                                                                                                                  ↓Dendritic spine density                              

                                                                                           Fixed brain (layer II/III visual cortex at P42)                        ↓Dendritic spine density                              [@B16]

                                                                                           Fixed brain (layer V motor cortex at P60)                              ↓Dendritic spine density                              [@B105]

                                                          Hippocampus                      Fixed brain (CA1 region at P7)                                         ↓Dendritic spine density                              [@B21]

                                                                                           Fixed brain (CA1 region at P21)                                        ↓Dendritic spine density                              [@B7]

                                                                                           Fixed brain (newly matured DG neurons at P56)                          ↓Dendritic spine density                              [@B100]

  *Mecp2* knockdown                                       Cortex                           Primary culture (layer II/III visual cortex at DIV7-9)                 ↓Excitatory synapse number                            [@B9]

                                                          Hippocampus                      Slice culture (CA1 region at DIV11)                                    ↓Dendritic spine density\                             [@B22]
                                                                                                                                                                  ↓Mature spines                                        

  *Mecp2*^Tg1^                                            Cortex                           *In vivo* (layer V somatosensory cortex at P56)                        ↑Dendritic spine density                              [@B48]

                                                          Hippocampus                      Autaptic culture (DIV7--9)                                             ↑Excitatory synapse number                            [@B20]

  Overexpression of *MECP2*                               Cortex                           Primary culture (DIV6)                                                 ↑Dendritic complexity                                 [@B49]

                                                                                           Primary culture (DIV6)                                                 ↓Dendritic complexity                                 [@B29]

                                                          Hippocampus                      Slice culture (pyramidal neurons at DIV7)                              ↓Dendritic complexity\                                [@B120]
                                                                                                                                                                  ↑Thin spines                                          

                                                                                           Slice culture (pyramidal neurons at DIV9)                              ↓Dendritic complexity\                                [@B29]
                                                                                                                                                                  ↓Dendritic spine density                              

                                                                                           Slice culture (CA1 region at DIV9)                                     ↓Dendritic spine density\                             [@B22]
                                                                                                                                                                  ↓Mature spines                                        

  Overexpression of *MECP2* mutations (R106W and T158M)   Hippocampus                      Slice culture (CA1 region at DIV9--11)                                 ↓Dendritic spine density\                             [@B22]
                                                                                                                                                                  ↓Mature spines                                        
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ROLE OF BDNF IN DENDRITIC SPINE FORMATION AND PLASTICITY: A POTENTIAL THERAPY FOR RTT
=====================================================================================

MeCP2 regulates the expression of thousands of genes, including brain-derived neurotrophic factor (*Bdnf*; [@B26]; [@B63]; [@B120]). BDNF is well known to promote neuronal and synaptic maturation ([@B15]), increase dendritic spine density, and enhance synaptic plasticity and learning and memory ([@B37]; [@B60]). MeCP2 binds to the *Bdnf* promoter and modulates *Bdnf* expression in an activity-dependent manner ([@B26]; [@B63]; [@B120]; [@B18]). Lower *Bdnf* mRNA and BDNF protein levels, as well as impaired BDNF trafficking and activity-dependent release, have been highlighted as pathophysiological mechanisms of RTT disease progression ([@B19]; [@B111]; [@B76]; [@B58]; [@B112]). Indeed, overexpression of BDNF rescues several cellular and behavioral deficits in *Mecp2* KO mice ([@B19]; [@B18]). These studies indicate that BDNF plays a critical role in neurological impairments in MeCP2-deficient mice.

Several studies have demonstrated that BDNF participates in synaptic plasticity, and is critical for dendritic spine formation and maturation during development ([@B83]; [@B106]; [@B103]; [@B31]; [@B110]). For example, exogenously applied BDNF increases spine density in cultured hippocampal neurons and CA1 pyramidal neurons in slice cultures ([@B108]; [@B47]). In addition, BDNF shifts the proportions of morphological types of spines in hippocampal slice cultures ([@B109]; [@B24]). Moreover, overexpression of the *Bdnf* gene in cultured hippocampal neurons rescued the dendritic atrophy caused by shRNA-mediated *Mecp2* knockdown ([@B56]). These effects of BDNF on dendritic spines are mediated by the tropomyosin related kinase B (TrkB) receptor ([@B108]), and subsequent activation of extracellular signal-regulated kinase (ERK; [@B1]), phosphatidylinositol 3-kinase (PI3K; [@B54]), and phospholipase C-γ (PLC-γ), which leads to the opening of canonical transient receptor potential (TRPC) channels containing the TRPC3 subunit ([@B2]; [@B23]; [@B58]; [@B60]; **Figure [1C](#F1){ref-type="fig"}**).

Activity-dependent release of endogenously expressed (native) BDNF also modulates spine morphology in conjunction with spontaneous neurotransmitter release ([@B107]; [@B109]; [@B103]). In addition, proper secretory trafficking of BDNF is essential for its actions on dendritic spine development and plasticity. The human *BDNF* gene has a single nucleotide polymorphism -- a methionine (met) substitution for valine (val) at codon 66 -- that impairs BDNF trafficking and its activity-dependent release, resulting in cognitive dysfunction in the general population ([@B34]; [@B28]), as well as more severe neurological symptoms in RTT individuals ([@B116]). Consistently, dendritic complexity is reduced in dentate granule cells of Val66Met knock-in mice ([@B27]). Therefore, expression of this *BDNF* polymorphism might lead to deleterious effects on dendritic spine density and morphology.

The main limitation of BDNF-based therapies for neurological disorders, including RTT, is its poor blood-brain barrier permeability. Synthetic BDNF-loop mimetics with selective TrkB agonist activity are exciting alternatives ([@B64]; [@B50]). Indeed, systemic treatment with LM22A-4 rescues respiratory deficits in female *Mecp2* heterozygous mice ([@B95]), and prevents spine loss in striatal medium-spiny neurons in a mouse model of Huntington's, rescuing their motor deficits ([@B99]).

Other intriguing substitutes for BDNF are insulin-like growth factor-1 (IGF-1) and its active tripeptide (\[1--3\]IGF-1, also known as glypromate, GPE), a hormone widely expressed in the CNS during brain development that promotes neuronal survival as well as synaptic maturation ([@B33]; [@B77]; [@B105]). Indeed, systemic treatment of male *Mecp*2 KO mice with \[1--3\]IGF-1 significantly increased activity of signaling pathways downstream of TrkB and improved several RTT-like symptoms and increased dendritic spine density in cortical neurons ([@B105]), effects that are all recapitulated by full-length IGF-1 ([@B16]). These effects are due to the activation of IGF-1 receptors directly by IGF-1, and indirectly by \[1--3\]IGF-1, which does not bind to the IGF-1 receptor but rather increases the expression of IGF-1 ([@B14]; [@B32]). It should be noted that full-length IGF-1 worsened a metabolic syndrome in *Mecp2* KO mice, and did not affect dendritic spine density in hippocampal neurons ([@B82]). The safety and efficacy of recombinant human full-length IGF-1 (mecasermin) in a Phase-1 clinical trial in RTT individuals have been recently reported ([@B53]). The \[1--3\]IGF-1 analog glycyl-[L]{.smallcaps}-methylprolyl-[L]{.smallcaps}-glutamic acid (NNZ-2566; Neuren Pharmaceuticals) is in a Phase-2 clinical trial in RTT individuals.

CONCLUSION
==========

Activity-dependent plasticity of dendritic spines includes both the formation of new spines and their maturation from thin, filipodia-like protrusions to "memory spines" that accompany excitatory synapse formation during brain development, as well as the structural remodeling of already existing spines. Alterations in neuronal circuitry are due to, or at least reflected by, deficits in dendritic spine structure and function. Dendritic spine anomalies have been identified in multiple brain regions in RTT and *Mecp2*-based mouse models. Since BDNF promotes the formation, maintenance, and activity-dependent sculpting of dendritic spines, and plays a critical role in neurological dysfunction in RTT, it emerges as one of the most exciting therapeutic agents for RTT. Thus, treatments that target the BDNF receptor TrkB and/or its downstream signaling pathways stand out as strong candidates to improve not only the spine dysgenesis phenotype, but also other synaptic plasticity deficits in RTT and other neurodevelopmental disorders caused by impaired BDNF availability.
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